GLP1RA-FGF21 fusion protein (Sanofi)

N/A

Report date: 2026/04/09 20:00:21

Base Information

Drug NameGLP1RA-FGF21 fusion protein (Sanofi)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsFibroblast growth factor 21 agonists
TargetsGlucagon-like peptide 1 receptorFibroblast growth factor 21
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A